Hologic appoints Vertex's Christiana Stamoulis to board
This article was originally published in Scrip
Diagnostics company Hologic has elected Christiana Stamoulis to its expanded board of directors and its corporate development committee. She is currently senior vice-president of corporate strategy and business development at Vertex Pharmaceuticals.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.